-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

503.O1.6 503. Clonal Hematopoiesis, Aging and Inflammation: Translational Innovations

Symposia: Clonal Hematopoiesis, Aging and Inflammation Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), CHIP, hematopoiesis, Diseases, immune mechanism, Myeloid Malignancies, Biological Processes, Technology and Procedures, Study Population, Minimal Residual Disease
Monday, December 11, 2023: 4:30 PM-6:00 PM
Room 24 (San Diego Convention Center)
Moderators:
Lachelle D. Weeks, MD, PhD, Dana Farber Cancer Institute and Sakshi Jasra, MD, University of Vermont Larner College of Medicine
Disclosures:
Weeks: Abbvie: Consultancy; Sobi: Membership on an entity's Board of Directors or advisory committees; Vertex: Consultancy.
4:30 PM

Nicole Prutsch, PhD1,2, Amélie Vromman, PhD2,3*, Brittaney Leeper, BS4*, Mengyu Chen, BS3*, Shuning He, PhD1*, Siyang Ren, MS5*, Christopher J. Walker, PhD6*, Mark W. Zimmerman, PhD1*, Mariana Janini Gomes, PhD3*, Eduardo J. Folco3*, Philipp J. Rauch, MD7,8, Prafulla C. Gokhale, PhD4*, Brian J. Abraham, PhD9*, Donna S. Neuberg, ScD5, Benjamin L. Ebert, MD, PhD7,8,10, Peter Libby, MD2,3* and A. Thomas Look, MD1,2

1Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
2equal contribution, Boston
3Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
4Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA
5Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
6Karyopharm Therapeutics Inc., Newton, MA
7Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
8Broad Institute of MIT and Harvard University, Cambridge, MA
9Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN
10Howard Hughes Medical Institute, Boston, MA

4:45 PM

Candice Quin, PhD1*, Erica DeJong, MSc1*, Amy J. M. McNaughton, PhD2*, Marco M. Buttigieg, BSc3*, Salman Basrai4*, Sagi Abelson5,6*, Margaret Larche, MBChB, PhD1*, Michael J. Rauh, MD, PhD2 and Dawn ME Bowdish, PhD7*

1McMaster University, Hamilton, ON, Canada
2Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada
3Queen's University, Kingston, ON, Canada
4Ontario Institute for Cancer Research, Mississauga, ON, Canada
5Ontario Institute for Cancer Research, Toronto, Canada
6University Health Network, Princess Margaret Cancer Centre, Toronto, Canada
7McMaster University, Hamilton, ON, CAN

5:00 PM

Adriana Chiaramida1*, Sandra G. Obwar1*, Gabriel K. Griffin, MD1*, Anja E.H. Nordstrom2*, Maria Ericsson, PhD2*, Dilshad H. Khan, PhD1* and Roger Belizaire, MD, PhD3

1Department of Pathology, Dana-Farber Cancer Institute, Boston, MA
2Department of Cell Biology, Harvard Medical School, Boston, MA
3Department of Pathology, Dana-Farber Cancer Institute, Inc., Boston, MA

5:15 PM

J. Scott Beeler, MD, PhD1*, Duc Tran2*, Jie Liu, MBBS, MPH2, Zilan Xin2*, Brian Wiley2*, Irenaeus C.C. Chan, MSc2*, Michael H. Kramer, MD, PhD3, Armel L. Batchi-Bouyou, MD2*, Xiaoyu Zong, MPH4*, Matthew J. Walter, MD2, Sarantis Chlamydas, PhD5*, Francesca Ferraro2, Stephen T. Oh, MD, PhD6, Ben Busby, PhD7*, Daniel C. Link, MD2, Yin Cao, ScD, MPH4* and Kelly L. Bolton, MD2

1Department of Medicine, Washington University School of Medicine, St. Louis, MO
2Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
3Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO
4Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis
5Olink Proteomics, Uppsala, Sweden
6Department of Medicine, Washington University School of Medicine, Saint Louis, MO
7DNAnexus, Mountain View, CA

5:30 PM

Yifan Zhou, BS, MS1,2,3*, Diana M Abraham, BA4*, Taha Bartu Hayal, PhD5*, Ashley Laurel Gin5*, Xing Fan, MD, PhD4*, Byung-Chul Lee, BS, PhD6,7,8*, Taehoon Shin, PhD6,9*, Rohan V Hosuru, BS4*, Elizabeth Lake Potter, PhD10*, So Gun Hong, DVM, PhD5, Mario Roederer, PhD10*, George Vassiliou, FRCPath, MRCP, PhD, MBBS1,11,12, Cynthia E. Dunbar, MD5 and Chuanfeng Wu, MD, Ph.D5*

1Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
2Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda
3Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
4Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
5Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
6Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, BETHESDA, MD
7Department of Biological Sciences, Sookmyung Women’s University, Seoul, Korea, Republic of (South)
8Research Institute of Women’s Health, Sookmyung Women’s University, Seoul, Korea, Republic of (South)
9Department of Laboratory Animal Medicine, College of Veterinary Medicine, Jeju National University, Jeju, Korea, Republic of (South)
10Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
11Department of Haematology, University of Cambridge, Cambridge, United Kingdom
12Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom

5:45 PM

Johannes Schetelig, MD, MSc1,2, Frederik Damm, MD3*, Ulf - Peter Günther, Dr.4*, Henning Baldauf2*, Carina Rave5*, Linda Koster6*, Gerhard Schöfl, Dr.4*, Anja Klussmeier, Dr.4*, Kamal Menghrajani, MD7, Kelly L. Bolton, MD8, Elke Rücker-Braun, PhD2,9*, Falk Heidenreich, PhD9,10*, Marie Münn4*, Markus Fuhrmann4*, Ilaria Visco4*, Mareike Frick, MD11*, Raphael Hablesreiter12*, Christopher Maximilian Arends12*, Liesbeth C. de Wreede, PhD13*, Olena Nesterenko, MD14*, Matthias Stelljes, MD15, Gesine Bug, MD16*, Thomas Schröder, MD17*, Ivan Sergeevich Moiseev, MD18*, Helene Schoemans19*, Christian Koenecke, MD20, Raphael Teipel, MD21*, Malte von Bonin, MD22*, Lars Bullinger23, Martin Bornhäuser, MD24*, Marcel R.M. van den Brink25, Alexander H. Schmidt, Dr.2*, Vinzenz Lange, Dr.26*, Zinaida Peric, MD PhD27* and Olaf Penack, MD28*

1TU Dresden, Dresden, Saxony, Germany
2DKMS Group gGmbH, Dresden, Germany
3Department of Hematology, Oncology and Tumor Immunology, Campus Virchow, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
4DKMS Life Science Lab, Dresden, Germany
5Clinical Trials Unit, DKMS Group gGmbH, Dresden, Germany
6EBMT Leiden Study Unit, Leiden, Netherlands
7MSKCC Memorial Sloan Kettering Cancer Center, New York, NY
8Department of Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University School of Medicine, Saint Louis, MO, Washington University In St Louis, St Louis, MO
9University Hospital Dresden, Dresden, Germany
10DKMS Ggmbh, Clinical Trials Unit, Dresden, Germany
11Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany
12Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany
13Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands
14Department of Clinical Transfusiology of Blood Service Center, National specialized children's hospital «Ohmatdyt», Kyiv, Ukraine
15University of Muenster, Muenster, Germany
16Klinik fuer Innere Medzin III, Ulm, Germany
17Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany
18St Petersburg University, St Petersburg, Russian Federation
19University Hospitals Leuven and KU Leuven, Leuven, Belgium
20Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
21Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
22Department of Internal Medicine I, University Hospital, TU Dresden, Dresden, Germany
23Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany
24Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
25Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
26DKMS Life Science Lab Dresden, Dresden, Germany
27University of Zagreb, Zagreb, Croatia
28Department of Hematology, Oncology, and Cancer Immunology, Charité Universitätsmedizin Berlin, Campus Virchow Klinik, Berlin, Germany

*signifies non-member of ASH